Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol target-controlled infusion model accuracy study
ChiCTR1800020437Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol (4 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoints: Blood propofol concentration and Exhaled propofol concentration. Started Jan 2019; status: recruiting.
02
Drugs
propofol
Beyond the preview
Go deeper on ChiCTR1800020437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020437.